According to Molecular Partners's latest financial reports the company has $0.22 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.26 B | 85.54% |
2021-12-31 | $0.14 B | -26.24% |
2020-12-31 | $0.19 B | 100.75% |
2019-12-31 | $98.15 M | -2.43% |
2018-12-31 | $0.10 B | -30.55% |
2017-12-31 | $0.14 B | -18.12% |
2016-12-31 | $0.17 B | -18.85% |
2015-12-31 | $0.21 B | 14.4% |
2014-12-31 | $0.19 B | 75.88% |
2013-12-31 | $0.10 B |